About Norgine
Norgine is a leading European specialist pharmaceutical company that has been bringing transformative products to patients for over a century.
Norgines commitment to transforming people’s lives drives everything they do and their European experience, fully integrated infrastructure and exceptional partnership approach enables them to quickly apply creative solutions to bring life-changing products to patients that they may not otherwise be able to access.
Norgine is proud to have helped 24 million patients around the world in 2021 and generated €505 million in net product sales, a growth of 10% over 2020.
Norgine specializes in gastroenterology, hepatology, cancer and supportive care.
Norgine is headquartered in the Netherlands.
For more information, please visit www.norgine.com.
In 2012, Norgine launched the additional business unit Norgine Ventures, which supports innovative companies in the healthcare industry by providing outside capital in Europe and the USA. For more information, please visit www.norgineventures.com.
NORGINE and the Norgine sail are registered trademarks of the Norgine group of companies.